Genesis Lifestyle Medicine

Genesis Lifestyle Medicine operates in Fort Worth, Texas, providing peptide-based therapies and medical weight management programs that combine pharmaceutical interventions with hormone optimization protocols. The clinic structures its services around GLP-1 receptor agonist medications—specifically semaglutide and tirzepatide—alongside growth hormone secretagogues and cellular restoration treatments designed for patients seeking metabolic improvement and body composition changes. With a 4.9-star rating across 214 Google reviews, the practice has established a patient base that frequently discusses measurable weight loss outcomes and the clinical team's responsiveness to individual questions throughout treatment cycles.

The peptide therapy menu at Genesis Lifestyle Medicine includes semaglutide and tirzepatide for appetite regulation and glycemic control, sermorelin for growth hormone release stimulation, and NAD+ infusions targeting cellular energy metabolism and mitochondrial function. Semaglutide protocols typically begin at lower doses with titration schedules adjusted based on tolerance and weight loss velocity, while tirzepatide programs incorporate dual GIP/GLP-1 receptor activation for patients who may benefit from enhanced metabolic effects. Sermorelin administration follows evening dosing patterns to align with natural growth hormone pulsatility, and NAD+ treatments are delivered via intravenous infusion with session durations ranging from two to four hours depending on dosage and patient response. The clinic also integrates aesthetic services including botulinum toxin injections, allowing patients to address both metabolic health and cosmetic concerns within a single treatment relationship.

Providers at Genesis Lifestyle Medicine in Fort Worth conduct initial consultations that include metabolic panel analysis, body composition assessment, and hormone level evaluation to determine appropriate peptide therapy candidates. The clinical approach emphasizes patient education regarding injection techniques, expected timelines for physiological changes, and potential side effects specific to each peptide class. Patients receive detailed information about administration schedules, storage requirements for temperature-sensitive peptides, and protocols for managing common GLP-1-related effects such as nausea or altered bowel patterns. The team structures follow-up intervals based on treatment type, with weekly check-ins common during early semaglutide or tirzepatide titration phases and monthly assessments once patients reach maintenance dosing.

The patient experience at Genesis Lifestyle Medicine involves both in-office visits and remote monitoring options, reflecting the clinic's hybrid consultation model that accommodates Fort Worth residents and patients from surrounding Tarrant County areas. Initial appointments occur at the physical location where staff demonstrate proper injection technique and provide starter supplies, while subsequent medication refills and progress evaluations can often be managed through telehealth platforms. Patients report that the office staff maintains accessibility for questions between scheduled appointments, particularly during the adjustment period when side effects or dosing concerns arise. The clinic provides injection supplies, sharps disposal containers, and written protocols that patients reference when self-administering peptides at home.

Genesis Lifestyle Medicine differentiates its Fort Worth practice through the integration of multiple peptide modalities rather than single-agent approaches, allowing providers to construct combination protocols for patients with overlapping goals in weight management, hormone balance, and cellular health. The clinic's willingness to incorporate aesthetic treatments alongside metabolic therapies creates continuity for patients pursuing comprehensive wellness improvements without coordinating care across multiple practices. The hybrid service model addresses practical barriers for patients balancing treatment compliance with work schedules and family obligations, while the established review profile suggests consistent execution of clinical protocols and patient communication standards across a substantial volume of treatment relationships.